' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

KOLLER ULRICH
Universitätsklinik für Dermatologie
Forschungsprogramm für Molekulare Therapie bei Genodermatosen

Publikationen | Forscherprofil

127 Publikationen

2022

Beiträge in Fachzeitschriften

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
Bischof, J; March, OP; Liemberger, B; Haas, SA; Hainzl, S; Petković, I; Leb-Reichl, V; Illmer, J; Korotchenko, E; Klausegger, A; Hoog, A; Binder, HM; Garcia, M; Duarte, B; Strunk, D; Larcher, F; Reichelt, J; Guttmann-Gruber, C; Wally, V; Hofbauer, JP; Bauer, JW; Cathomen, T; Kocher, T; Koller, U;
Mol Ther. 2022; 30(8): 2680-2692.
Originalarbeiten (Zeitschrift)
Current developments in gene therapy for epidermolysis bullosa.
Kocher, T; Petkovic, I; Bischof, J; Koller, U;
Expert Opin Biol Ther. 2022; 22(9): 1137-1150.
Originalarbeiten (Zeitschrift)
Molecular Research and Treatment of Skin Diseases.
Koller, U; Bauer, JW;
Int J Mol Sci. 2022; 23(10):
Editorials
5'RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
Mayr, E; Ablinger, M; Lettner, T; Murauer, EM; Guttmann-Gruber, C; Piñón Hofbauer, J; Hainzl, S; Kaiser, M; Klausegger, A; Bauer, JW; Koller, U; Wally, V;
Int J Mol Sci. 2022; 23(3):
Originalarbeiten (Zeitschrift)
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.
Petković, I; Bischof, J; Kocher, T; March, OP; Liemberger, B; Hainzl, S; Strunk, D; Raninger, AM; Binder, HM; Reichelt, J; Guttmann-Gruber, C; Wally, V; Piñón Hofbauer, J; Bauer, JW; Koller, U;
Front Med (Lausanne). 2022; 9: 976604
Originalarbeiten (Zeitschrift)
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Woess, K; Sun, Y; Morio, H; Stierschneider, A; Kaufmann, A; Hainzl, S; Trattner, L; Kocher, T; Tockner, B; Leb-Reichl, V; Steiner, M; Brachtl, G; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Wally, V; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C;
Int J Mol Sci. 2022; 23(1):
Originalarbeiten (Zeitschrift)
Transcriptome-Guided Drug Repurposing for Aggressive SCCs.
Zauner, R; Wimmer, M; Dorfer, S; Ablinger, M; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C; Bauer, JW; Wally, V;
Int J Mol Sci. 2022; 23(2):
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Efficient homology-directed repair CRISPR/Cas9-based gene editing in junctional epidermolysis bullosa keratinocytes
Petkovic, I; Bischof, J; Liemberger, B; March, OP; Reichelt, J; Binder, H; Strunk, D; Bauer, JW; Kocher, T; Koller, U
EXP DERMATOL. 2022; 31(2): E32-E32.
Abstracts (Zeitschrift)

2021

Beiträge in Fachzeitschriften

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
Ablinger, M; Lettner, T; Friedl, N; Potocki, H; Palmetzhofer, T; Koller, U; Illmer, J; Liemberger, B; Hainzl, S; Klausegger, A; Reisenberger, M; Lambert, J; Van Gele, M; Desmet, E; Van Maelsaeke, E; Wimmer, M; Zauner, R; Bauer, JW; Wally, V;
Int J Mol Sci. 2021; 22(7):
Originalarbeiten (Zeitschrift)
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
Bornert, O; Hogervorst, M; Nauroy, P; Bischof, J; Swildens, J; Athanasiou, I; Tufa, SF; Keene, DR; Kiritsi, D; Hainzl, S; Murauer, EM; Marinkovich, MP; Platenburg, G; Hausser, I; Wally, V; Ritsema, T; Koller, U; Haisma, EM; Nyström, A;
J Invest Dermatol. 2021; 141(4):883-893.e6
Originalarbeiten (Zeitschrift)
A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
Kocher, T; Bischof, J; Haas, SA; March, OP; Liemberger, B; Hainzl, S; Illmer, J; Hoog, A; Muigg, K; Binder, HM; Klausegger, A; Strunk, D; Bauer, JW; Cathomen, T; Koller, U;
Mol Ther Nucleic Acids. 2021; 25: 237-250.
Originalarbeiten (Zeitschrift)
Advances in gene editing strategies for epidermolysis bullosa.
Kocher, T; Koller, U;
Prog Mol Biol Transl Sci. 2021; 182: 8-109.
Originalarbeiten (Zeitschrift)
Gene Replacement Therapies for Genodermatoses: A Status Quo
Koller, U; Bauer, JW;
Front Genet. 2021; 12: 658295
Übersichtsarbeiten
Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases
Kwik, M; Hainzl, S; Oppelt, J; Tichy, B; Koller, U; Bernardinelli, E; Steiner, M; Zara, G; Nofziger, C; Weis, S; Paulmichl, M; Dossena, S; Patsch, W; Soyal, SM;
Int J Mol Sci. 2021; 22(7):
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Double-nicking-based correction of junctional epidermolysis bullosa via COL17A1 reframing
Bischof, J; March, OP; Haas, SA; Liemberger, B; Hainzl, S; Hoog, A; Binder, H; Duarte, B; Strunk, D; Larcher, F; Reichelt, J; Bauer, JW; Cathomen, T; Kocher, T; Koller, U
EXP DERMATOL. .. 2021; 30(3):E44-E44.
Abstracts (Zeitschrift)
CAST-Seq discloses low frequency of chromosomal rearrangements in double-nickase based genome editing in primary human cells
Klermund, J; Rhiel, M; Kocher, T; Bischof, J; Hainzl, S; Andrieux, G; el Gaz, M; Cornu, TI; Koller, U; Cathomen, T
HUM GENE THER. 2021; 32(19-20): A64-A64.
Abstracts (Zeitschrift)
Development of a non-invasive and non-viral in vivo RNA therapy approach for dystrophic epidermolysis bullosa
Liemberger, B; Kocher, T; Lettner, T; Ablinger, M; Reichl, V; Lackner, N; Peking, P; Murauer, EM; Nystrom, A; Wally, V; Mayr, E; Guttmann-Gruber, C; Bauer, JW; Koller, U
EXP DERMATOL. 2021; 30(3): E43-E43.
Abstracts (Zeitschrift)
COL17A1 editing in junctional epidermolysis bullosa keratinocytes via CRISPR/Cas9 induced homology-directed repair
Petkovic, I; Bischof, J; Liemberger, B; Kocher, T; March, OP; Reichelt, J; Binder, HM; Strunk, D; Bauer, JW; Koller, U
HUM GENE THER. 2021; 32(19-20): A65-A65.
Abstracts (Zeitschrift)
CRISPR/Cas9 nickase mediated gene therapy in primary keratinocytes derived from patients with EPPK
Trafoier, T; Hainzl, S; Kocher, T; Koller, U; Reichelt, J; Tiefenthaler, CH; Schmuth, M
J INVEST DERMATOL. 2021; 141(10): S175-S175.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

Gene-Editing-Strategien für Genodermatosen
Kocher, T; Koller, U;
Spectrum Dermatologie. 2021.

2020

Beiträge in Fachzeitschriften

Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa.
Kocher, T; March, OP; Bischof, J; Liemberger, B; Hainzl, S; Klausegger, A; Hoog, A; Strunk, D; Bauer, JW; Koller, U;
J Invest Dermatol. 2020; 140(10):1985-1993.e5
Originalarbeiten (Zeitschrift)
[Ex vivo stem cell gene therapy of the skin : Ready for clinical use?]
Koller, U;
Hautarzt. 2020; 71(2):85-90
Übersichtsarbeiten
Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses.
March, OP; Kocher, T; Koller, U;
Cells. 2020; 9(1):
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

PAIRED SPCAS9 D10A RNPS PRODUCE THE SUBSTRATE FOR EFFICIENT GENE REPAIR VIA HOMOLOGOUS RECOMBINATION IN RDEB PATIENT KERATINONOCYTES
Kocher, T; Cathomen, T; Haas, S; Hoog, A; Strunk, D; Bauer, JW; Koller, U
ACTA DERM-VENEREOL. 2020; 100: 34-35.
Abstracts (Zeitschrift)
COL17A1 EDITING USING CRISPR/CAS9
Koller, U
ACTA DERM-VENEREOL. 2020; 100: 13-13.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Paired SpCas9 D10A RNPs produce the substrate for efficient gene repair via homologous recombination in RDEB patient keratinocytes.
Kocher, T; Cathomen, T; Haas, S; Hoog, A; Strunk, D; Bauer, JW; Koller, U;
EB2020; 19.-23.01.2020; London. 2020.
COL17A1 editing using CRISPR/Cas9
Koller, U
EB2020; 19-23.01.2020; London. 2020.
A non-viral in vivo RNA therapy approach for dystrophic epidermolysis bullosa
Liemberger, Bernadette; Kocher, Thomas; Lackner, Nina; Peking, Patricia; Murauer, Eva M.; Mayr, Elisabeth; Guttmann-Gruber, Christina; Bauer, Johann W.; Koller, Ulrich;
ÖGDC Science Days 2020; 16.01 - 18.01.2020; Mondsee. 2020.
Paired nickase-mediated correction of junctional epidermolysis bullosa via COL17A1 reframing
March, O.; Bischof, J.; Kocher, T.; Liemberger, B.; Hainzl, S.; Haas, S.; Cathomen, T.; Hoog, A.; Strunk, D.; Reichelt, J.; Bauer, J. W.; Koller, u.;
ÖGDV Science Days ; 16.-18.01.2020; Schlosshotel Mondsee. 2020.
Paired SpCas9 D10A RNPs produce the substrate for efficient gene repair via homologous recombination in RDEB patient keratinocytes
Thomas Kocher / Toni Cathomen / Simone Haas / Anna Hoog / Dirk Strunk /Johann W Bauer / Ulrich Koller
2020; -EB2020; 19.01.-23.01.2020; London.

Beiträge in Sonstigen Zeitschriften

Gentherapeutische Ansätze für die Epidermolysis bullosa
Koller, U
JATROS Dermatologie & Plastische Chirurgie. 2020. 1: 20-1.

2019

Beiträge in Fachzeitschriften

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies.
Bornert, O; Kocher, T; Gretzmeier, C; Liemberger, B; Hainzl, S; Koller, U; Nyström, A;
Matrix Biol Plus. 2019; 4:100017
Originalarbeiten (Zeitschrift)
Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination.
Kocher, T; Wagner, RN; Klausegger, A; Guttmann-Gruber, C; Hainzl, S; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther Nucleic Acids. 2019; 18:496-507
Originalarbeiten (Zeitschrift)
Gene Editing-Mediated Disruption of Epidermolytic Ichthyosis-Associated KRT10 Alleles Restores Filament Stability in Keratinocytes.
March, OP; Lettner, T; Klausegger, A; Ablinger, M; Kocher, T; Hainzl, S; Peking, P; Lackner, N; Rajan, N; Hofbauer, JP; Guttmann-Gruber, C; Bygum, A; Koller, U; Reichelt, J;
J Invest Dermatol. 2019; 139(8): 1699-1710.e6.
Originalarbeiten (Zeitschrift)
An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.
Peking, P; Breitenbach, JS; Ablinger, M; Muss, WH; Poetschke, FJ; Kocher, T; Koller, U; Hainzl, S; Kitzmueller, S; Bauer, JW; Reichelt, J; Lettner, T; Wally, V;
Br J Dermatol. 2019; 180(1):141-148
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A selection-free COL7A1 repair strategy based on homologous recombination
Kocher, T; Wagner, RN; Cathomen, T; Haas, S; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2019; 30(11): A177-A177.
Abstracts (Zeitschrift)
Highly efficient paired nickase-mediated correction of junctional epidermolysis bullosa via COL17A1 reframing
March, OP; Kocher, T; Liemberger, B; Bischof, J; Hainzl, S; Haas, S; Hochreiter, A; Strunk, D; Cathomen, T; Reichelt, J; Bauer, JW; Koller, U
HUM GENE THER. 2019; 30(11): A173-A173.
Abstracts (Zeitschrift)
Gene editing as a therapeutic option for epidermolytic ichthyosis
March, OP; Lettner, T; Klausegger, A; Ablinger, M; Kocher, T; Hainzl, S; Peking, P; Lackner, N; Aushev, M; Koller, U; Reichelt, J
EXP DERMATOL. 2019; 28(3): E45-E45.
Abstracts (Zeitschrift)
Correction of type XVII collagen using spliceosome-mediated RNA trans-splicing
Reisenberger, M; Schlager, P; Reichelt, J; Bauer, JW; Koller, U; Hainzl, S; Ablinger, M; Lettner, T; Wally, V
EUR J HUM GENET. 2019; 27: 109-110.
Abstracts (Zeitschrift)

2018

Beiträge in Fachzeitschriften

Advances on potential therapeutic options for epidermolysis bullosa
De Rosa, L; Koller, U; Bauer, JW; De Luca, M; Reichelt, J
EXPERT OPIN ORPHAN D. 2018; 6(4): 283-293.
Übersichtsarbeiten
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U;
Int J Mol Sci. 2018; 19(3):
Originalarbeiten (Zeitschrift)
Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
March, OP; Reichelt, J; Koller, U;
Exp Physiol. 2018; 103(4):449-455
Originalarbeiten (Zeitschrift)
Functional therapies for cutaneous wound repair in epidermolysis bullosa.
Peking, P; Koller, U; Murauer, EM;
Adv Drug Deliv Rev. 2018; 129:330-343
Originalarbeiten (Zeitschrift)
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun, Y; Hofbauer, JP; Harada, M; Wöss, K; Koller, U; Morio, H; Stierschneider, A; Kitamura, K; Hashimoto, M; Chiba, K; Akita, H; Anzai, N; Reichelt, J; Bauer, JW; Guttmann-Gruber, C; Furihata, T;
Cancer Lett. 2018; 433: 107-116.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Keratin 14 labelling with a fluorescence molecule facilitates efficiency analysis of RNA therapeutics in epidermolysis bullosa simplex
Kocher, T; Liemberger, B; Tischlinger, K; Steiner, M; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2018; 29(12): A95-A95.
Abstracts (Zeitschrift)
Keratin 14 labelling with a fluorescence molecule facilitates efficiency analysis of RNA therapeutics in epidermolysis bullosa simplex
Kocher, T; Liemberger, B; Tischlinger, K; Steiner, M; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2018; 29(12): A95-A95.
Abstracts (Zeitschrift)
A minicircle-based screening system facilitates the selection of promising CRISPR/Cas9 double nicking pairs for homology-directed repair of genetic mutations
Kocher, T; Wagner, R; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2018; 29(12): A105-A105.
Abstracts (Zeitschrift)
A minicircle-based screening system facilitates the selection of promising CRISPR/Cas9 double nicking pairs for homology-directed repair of genetic mutations
Kocher, T; Wagner, R; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2018; 29(12): A105-A105.
Abstracts (Zeitschrift)
Functional characterization of reference and CNS-specific PGC-1alpha proteins in SH-SY5Y neuroblastoma cells
Kwik, M; Koller, U; Hainzl, S; Bernardinelli, E; Dossena, S; Patsch, W; Soyal-Patsch, S;
Functional characterization of reference and CNS-specific PGC-1alpha proteins in SH-SY5Y neuroblastoma cells. 2018; -Paracelsus Science Get Together; 29.06.2018; Salzburg.
Abstracts (Zeitschrift)
TALEN-mediated inactivation of dominant-negative keratin alleles for general phenotypic alleviation of epidermolytic ichthyosis
March, OP; Kocher, T; Lackner, N; Hainzl, S; Lettner, T; Ablinger, M; Klausegger, A; Koller, U; Reichelt, J
HUM GENE THER. 2018; 29(12): A114-A114.
Abstracts (Zeitschrift)
TALEN-mediated inactivation of dominant-negative keratin alleles results in the formation of a stable functional cytoskeleton and phenotypic alleviation of epidermolytic ichthyosis
March, OP; Kocher, T; Lettner, T; Ablinger, M; Lackner, N; Hainzl, S; Peking, P; Aushev, M; Koller, U; Reichelt, J
J INVEST DERMATOL. 2018; 138(5): S138-S138.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction.
Bernadette Liemberger, Nina Lackner, Claudia Arzt, Stefan Hainzl, Verena Wally, Thomas Kocher, Josefina Piñón Hofbauer, Eva M. Murauer, Johann W. Bauer, Julia Reichelt, Ulrich Koller
2nd International Caparica Conference in Splicing; 16.-19.07.2018; Caparica. 2018.
Col7A1 repair via RNA trans-splicing in a dystrophic epidermolysis bullosa mouse model
Ulrich Koller, Patricia Peking, Kocher Thomas, Alexander Nyström, Julia Reichelt, Johann W. Bauer, Eva M. Murauer
2nd International Caparica Conference in Splicing; 16.-19.07.2018; Caparica. 2018.

2017

Beiträge in Fachzeitschriften

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients.
Aushev, M; Koller, U; Mussolino, C; Cathomen, T; Reichelt, J;
Mol Ther Methods Clin Dev. 2017; 6: -123.
Originalarbeiten (Zeitschrift)
RNA-based therapies for genodermatoses.
Bornert, O; Peking, P; Bremer, J; Koller, U; van den Akker, PC; Aartsma-Rus, A; Pasmooij, AM; Murauer, EM; Nyström, A;
Exp Dermatol. 2017; 26(1):3-10
Übersichtsarbeiten
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther. 2017; 25(11):2573-2584
Originalarbeiten (Zeitschrift)
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther. 2017; 25(11):2585-2598
Originalarbeiten (Zeitschrift)
An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking, P; Koller, U; Duarte, B; Murillas, R; Wolf, S; Maetzig, T; Rothe, M; Kocher, T; García, M; Brachtl, G; Schambach, A; Larcher, F; Reichelt, J; Bauer, JW; Murauer, EM;
Nucleic Acids Res. 2017; 45(17): 1025-10269.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Ex vivo COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa
Hainzl, S; Peking, P; Kocher, T; Murauer, E; Larcher, F; Duarte, B; Steiner, M; Bauer, J; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(5): S92-S92.
Abstracts (Zeitschrift)
CRISPR/Cas9 mediated gene correction of COL7A1
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; del Rio, M; Duarte, BG; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S224-S224.
Abstracts (Zeitschrift)
Improved safety profile: An efficient CRISPR/Cas9 double nicking approach for KRT14 repair in EB simplex
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S225-S225.
Abstracts (Zeitschrift)
Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A57-A57.
Abstracts (Zeitschrift)
Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S229-S229.
Abstracts (Zeitschrift)
Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Pinon Hofbauer, J; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
Journal of Investigative Dermatology. 2017; S189: -Annual Meeting of the European Society for Dermatological Research; 27.-30.09.2017; Salzburg.
Abstracts (Zeitschrift)
Enhanced genome editing using split Staphylococcus aureus Cas9 delivered in self-complementary AAV vectors
Liemberger, B; Arzt, C; Hainzl, S; Wally, V; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A63-A63.
Abstracts (Zeitschrift)
TALEN-mediated gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy
March, O; Aushev, M; Koller, U; Reichelt, J
J INVEST DERMATOL. 2017; 137(5): S92-S92.
Abstracts (Zeitschrift)
TALEN-mediated gene editing in epidermolytic ichthyosis patient-derived keratinocytes
March, OP; Aushev, M; Koller, U; Reichelt, J
J INVEST DERMATOL. 2017; 137(10): S226-S226.
Abstracts (Zeitschrift)
RNA trans-splicing-mediated COL7A1 repair in a dystrophic epidermolysis bullosa mouse model
Peking, P; Koller, U; Kocher, T; Nystroem, A; Reichelt, J; Bauer, JW; Murauer, EM
J INVEST DERMATOL. 2017; 137(10): S229-S229.
Abstracts (Zeitschrift)

2016

Beiträge in Fachzeitschriften

Designing Efficient Double RNA trans-Splicing Molecules for Targeted RNA Repair.
Huttner, C; Murauer, EM; Hainzl, S; Kocher, T; Neumayer, A; Reichelt, J; Bauer, JW; Koller, U
Int J Mol Sci. 2016; 17(10):
Originalarbeiten (Zeitschrift)
A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.
Peking, P; Koller, U; Hainzl, S; Kitzmueller, S; Kocher, T; Mayr, E; Nyström, A; Lener, T; Reichelt, J; Bauer, JW; Murauer, EM;
Mol Ther Nucleic Acids. 2016; 5: e287
Originalarbeiten (Zeitschrift)
Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations.
Tockner, B; Kocher, T; Hainzl, S; Reichelt, J; Bauer, JW; Koller, U; Murauer, EM;
Gene Ther. 2016; 23(11):775-784
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Koller, U
HUM GENE THER. 2016; 27(11): A144-A144.
Abstracts (Zeitschrift)
CRISPR/Cas9-mediated gene repair in the COL7A1 gene
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)
Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)
Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2016; 27(11): A135-A135.
Abstracts (Zeitschrift)
Optimised TALEN-mediated gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy
March, O; Aushev, M; Koller, U; Reichelt, J
J INVEST DERMATOL. 2016; 136(9): S193-S193.
Abstracts (Zeitschrift)
Gene editing of keratinocyte stem cells for a novel ex vivo epidermolytic ichthyosis therapy
March, O; Aushev, M; Koller, U; Reichelt, J
EXP DERMATOL. 2016; 25(3): E17-E17.
Abstracts (Zeitschrift)
Developing an optimised TALEN-mediated ex vivo gene therapy for epidermolytic ichthyosis
March, ONP; Aushev, M; Koller, U; Reichelt, J
HUM GENE THER. 2016; 27(11): A144-A144.
Abstracts (Zeitschrift)
Long-term in vivo correction of a recessive dystrophic epidermolysis bullosa phenotype using RNA trans-splicing repair
Peking, P; Koller, U; Duarte, BG; Wolf, S; Murrillas, R; Diez, MG; Schambach, A; Larcher, F; Bauer, JW; Murauer, EM
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)
Optimised TALEN-mediated Gene Editing of Keratinocyte Stem Cells for a Novel Ex Vivo Epidermolytic Ichthyosis Therapy
Reichelt, J; March, O; Aushev, M; Koller, U
BRIT J DERMATOL. 2016; 175: 59-59.
Abstracts (Zeitschrift)

2015

Beiträge in Fachzeitschriften

Trans-splicing improvement by the combined application of antisense strategies.
Koller, U; Hainzl, S; Kocher, T; Hüttner, C; Klausegger, A; Gruber, C; Mayr, E; Wally, V; Bauer, JW; Murauer, EM;
Int J Mol Sci. 2015; 16(1):117-191
Originalarbeiten (Zeitschrift)
Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
Murauer, EM; Koller, U; Pellegrini, G; De Luca, M; Bauer, JW;
Keio J Med. 2015; 64(2): 21-25.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The design and analysis of double RNA trans-splicing molecules for COL7A1 repair
Huttner, C; Hainzl, S; Murauer, EM; Bauer, JW; Koller, U
HUM GENE THER. 2015; 26(10): A48-A48.
Abstracts (Zeitschrift)
The combined application of antisense-based strategies for RNA repair
Huttner, C; Murauer, EM; Hainzl, S; Kocher, T; Bauer, JW; Koller, U
HUM GENE THER. 2015; 26(10): A48-A48.
Abstracts (Zeitschrift)
A fluorescence-based screening system accelerates the design of RNA trans-splicing molecules for mRNA repair.
Kocher, T; Koller, U; Seyr, J; Hainzl, S; Mayer, E; Brachtl, G; Lener, T; Bauer, J; Wally, V; Murauer, E
J INVEST DERMATOL. 2015; 135: S60-S60.
Abstracts (Zeitschrift)
Analysis of binding characteristics of RNA trans-splicing molecules using a fluorescence-based screening system
Koller, U; Kocher, T; Seyr, J; Hainzl, S; Mayr, E; Tockner, B; Brachtl, G; Bauer, JW; Wally, V; Murauer, EM
EXP DERMATOL. 2015; 24(3): E16-E17.
Abstracts (Zeitschrift)
Pathological mechanisms underlying contracture formation in epidermolysis bullosa
Liemberger, B; Hainzl, S; Koller, U; Wally, V; Hofbauer, JP; Studnicka-Benke, A; Diem, A; Bauer, J; Breitenbach, J; Gruber, C
J INVEST DERMATOL. 2015; 135: S59-S59.
Abstracts (Zeitschrift)
Correction of type VII collagen in a murine recessive dystrophic epidermolysis bullosa model using RNA trans-splicing
Peking, P; Koller, U; Hainzl, S; Kocher, T; Mayr, E; Kitzmuller, S; Lener, T; Bruckner-Tudermann, L; Bauer, JW; Murauer, EM
HUM GENE THER. 2015; 26(10): A48-A48.
Abstracts (Zeitschrift)

2014

Beiträge in Fachzeitschriften

Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders.
Koller, U; Wally, V; Bauer, JW; Murauer, EM;
Mol Ther Nucleic Acids. 2014; 3: e157
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Internal exon replacement as a promising tool for COL7A1 RNA repair
Huttner, C; Hainzl, S; Murauer, EM; Bauer, JW; Koller, U
J INVEST DERMATOL. 2014; 134: S58-S58.
Abstracts (Zeitschrift)
Selection of antisense oligonucleotides for trans-splicing enhancement using a fluorescence-based screening system
Koller, U; Hainzl, S; Huttner, C; Kocher, T; Klausegger, A; Murauer, EM; Gruber, C; Mayr, E; Wally, V; Bauer, JW
J INVEST DERMATOL. 2014; 134: S61-S61.
Abstracts (Zeitschrift)
Correction of type VII collagen in dystrophic epidermolysis bullosa by novel trans-splicing molecules
Peking, P; Mayr, E; Koller, U; Hainzl, S; Kocher, T; Bauer, JW; Murauer, EM
J INVEST DERMATOL. 2014; 134: S56-S56.
Abstracts (Zeitschrift)
Spliceosome Mediated RNA Trans-Splicing for Targeting Kappa(+) B-Cell Neoplasms
Weiss, L; Gruber, C; Koller, U; Pinon-Hofbauer, J; Hainzl, S; Hufnagl, C; Melchardt, T; Brachtl, G; Greil, R; Bauer, J; Egle, A
BLOOD. 2014; 124(21):
Abstracts (Zeitschrift)

2013

Beiträge in Fachzeitschriften

RNA trans-splicing for genodermatoses.
Bauer, JW; Murauer, EM; Wally, V; Koller, U;
Methods Mol Biol. 2013; 961:441-455
Originalarbeiten (Zeitschrift)
The design and optimization of RNA trans-splicing molecules for skin cancer therapy.
Gruber, C; Koller, U; Murauer, EM; Hainzl, S; Huttner, C; Kocher, T; South, AP; Hintner, H; Bauer, JW
Mol Oncol. 2013; 7(6):105-168
Originalarbeiten (Zeitschrift)
A reporter-based screen to identify potent 3" trans-splicing molecules for endogenous RNA repair.
Murauer, EM; Koller, U; Hainzl, S; Wally, V; Bauer, JW;
Hum Gene Ther Methods. 2013; 24(1):19-27
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

RNA trans-splicing molecules for targeted suicide gene delivery into cancer cells
Gruber, C; Koller, U; Hainzl, S; Murauer, EM; Huttner, C; South, AP; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2013; 133: S64-S64.
Abstracts (Zeitschrift)
Blocking cis-splicing elements leads to increased RNA trans-splicing in the COL7A1 gene
Hainzl, S; Koller, U; Murauer, EM; Hintner, H; Bauer, JW
HUM GENE THER. 2013; 24(12): A130-A130.
Abstracts (Zeitschrift)
Double RNA trans-splicing induced gene repair of COL7A1
Huttner, C; Koller, U; Murauer, EM; Hainzl, S; Hintner, H; Bauer, JW
HUM GENE THER. 2013; 24(12): A128-A128.
Abstracts (Zeitschrift)
A screening system accelerates the design of RNA trans-splicing molecules for skin cancer therapy
Koller, U; Gruber, C; Murauer, EM; Hainzl, S; Huttner, C; Kocher, T; South, AP; Hintner, H; Bauer, JW
HUM GENE THER. 2013; 24(12): A129-A129.
Abstracts (Zeitschrift)
Pre-screening of trans-splicing molecules improves COL7A1 mRNA repair
Murauer, EM; Koller, U; Hainzl, S; Wally, V; Bauer, JW
HUM GENE THER. 2013; 24(12): A130-A131.
Abstracts (Zeitschrift)
A stable fluorescence-based COL7A1 mini gene expression cell line accelerates the design of efficient RNA trans-splicing repair molecules (RTMs)
Tockner, B; Koller, U; Murauer, ME; Hainzl, S; Hintner, H; Bauer, JW
HUM GENE THER. 2013; 24(12): A130-A130.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

Gene Therapy for the COL7A1 Gene
Mayr, E; Koller, U; Bauer, JW;
In: Dr. Francisco Martin Molina (Ed.) editors(s). Gene Therapy - Tools and Potential Applications. InTech; (ISBN: 978-953-51-1014-9)

2012

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Optimized high throughput screening system for RNA trans-splicing molecules for gene correction in epidermolysis bullosa
Hainzl, S; Koller, U; Murauer, E; Tockner, B; Wally, V; Hintner, H; Bauer, J
J INVEST DERMATOL. 2012; 132: S94-S94.
Abstracts (Zeitschrift)
Double RNA trans-splicing induced gene correction in epidermolysis bullosa
Koller, U; Hainzl, S; Klausegger, A; Wally, V; Murauer, EM; Mayr, E; Gruber, C; Mitchell, L; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S93-S93.
Abstracts (Zeitschrift)
Functional Correction of Mutations in COL7A1 in a RDEB Patient Cellline via 5 xxx trans-splicing
Mayr, E; Koller, U; Murauer, EM; Gruber, C; Kaiser, M; Klausegger, A; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S92-S92.
Abstracts (Zeitschrift)
Screening for highly efficient RTMs to improve 3 xxx trans-splicing for COL7A1 gene
Tockner, B; Murauer, EM; Mayr, E; Wally, V; Koller, U; Hainzl, S; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S95-S95.
Abstracts (Zeitschrift)

2011

Beiträge in Fachzeitschriften

Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells.
Gruber, C; Gratz, IK; Murauer, EM; Mayr, E; Koller, U; Bruckner-Tuderman, L; Meneguzzi, G; Hintner, H; Bauer, JW;
Mol Cancer Ther. 2011; 10(2): 233-241.
Originalarbeiten (Zeitschrift)
A novel screening system improves genetic correction by internal exon replacement.
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hainzl, S; Hintner, H; Bauer, JW;
Nucleic Acids Res. 2011; 39(16): e108
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Screening for high efficient double RNA trans-splicing molecules to exchange a single exon of the COL17A1 gene
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hainzl, S; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2011; 131: S67-S67.
Abstracts (Zeitschrift)
A 5 xxx trans-splicing gene therapy approach for dystrophic epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Gruber, C; Klausegger, A; Kaiser, M; Bruckner-Tuderman, L; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2011; 131: S68-S68.
Abstracts (Zeitschrift)
Optimization of 3 xxx trans-splicing in the type VII Collagen gene
Tockner, B; Murauer, EM; Gruber, C; Mayr, E; Schlager, P; Wally, V; Koller, U; Klausegger, A; Hintner, H; Bauer, JW
HUM GENE THER. 2011; 22(10): A53-A53.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

High-Throughput Screening for Highly Functional RNA-Trans-Splicing Molecules: Correction of Plectin in Epidermolysis Bullosa Simplex.
Wally, V; Koller, U; Bauer, JW;
In: Dijana Plaseska-Karanfilska (Ed.) editors(s). Human Genetic Diseases.. (ISBN: 978-953-307-936-3)

2010

Beiträge in Fachzeitschriften

K14 mRNA reprogramming for dominant epidermolysis bullosa simplex.
Wally, V; Brunner, M; Lettner, T; Wagner, M; Koller, U; Trost, A; Murauer, EM; Hainzl, S; Hintner, H; Bauer, JW;
Hum Mol Genet. 2010; 19(23):471-425
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Improvement of RNA trans-splicing based gene correction using a RTM screening system
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hintner, H; Bauer, JW
HUM GENE THER. 2010; 21(10): 1451-1451.
Abstracts (Zeitschrift)
Screening for the best 5 xxx pre-trans-splicing molecules in COL7A1 in order to develop a 5 xxx trans-splicing gene therapy approach for dystrophic Epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Gruber, C; Klausegger, A; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2010; 130: S80-S80.
Abstracts (Zeitschrift)
Keratin 14 mRNA trans-splicing in dominant Epidermolysis bullosa
Wally, V; Brunner, M; Lettner, T; Koller, U; Hintner, H; Bauer, JW
HUM GENE THER. 2010; 21(10): 1446-1446.
Abstracts (Zeitschrift)

2009

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

High throughput screening for functional RNA trans-splicing repair molecules (RTMs) for the correction of the gene PLEC1
Koller, U; Wally, V; Mitchell, L; Klausegger, A; Muraurer, E; Mayr, E; Brunner, M; Hintner, H; Bauer, J
HUM GENE THER. 2009; 20(11): 1530-1531.
Abstracts (Zeitschrift)
Using RNA Trans-splicing to correct mutations in the plectin gene
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)
5 xxx trans-splicing in the Type VII Collagen Gene - Development of a mRNA based Gene Therapy Approach for Dystrophic Epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Wally, V; Klausegger, A; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2009; 129: S46-S46.
Abstracts (Zeitschrift)
5# Trans-splicing in the type vii collagen gene-development of a mRNA based gene therapy approach for dystrophic epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Wally, V; Klausegger, A; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 284-284.
Abstracts (Zeitschrift)
3 xxx Trans-splicing as a tool for gene therapy in dystrophic epidermolysis bullosa
Murauer, EM; Gache, Y; Klausegger, A; Wally, V; Koller, U; Mayr, E; Meneguzzi, G; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)
Therapy of dominant Epidermolysis bullosa vie Spliceosome Mediated RNA Trans-splicing
Wally, V; Brunner, M; Koller, U; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2009; 129: S55-S55.
Abstracts (Zeitschrift)
Gene therapy for autosomal dominant diseases
Wally, V; Koller, U; Murauer, EM; Mayr, E; Klausegger, A; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)

2008

Beiträge in Fachzeitschriften

5" trans-splicing repair of the PLEC1 gene.
Wally, V; Klausegger, A; Koller, U; Lochmüller, H; Krause, S; Wiche, G; Mitchell, LG; Hintner, H; Bauer, JW;
J INVEST DERMATOL. 2008; 128(3): 568-574.
Originalarbeiten (Zeitschrift)

2007

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Correction of mutations in the plectin gene by RNA Trans-splicing
Koller, U; Wally, V; Hintner, H; Bauer, JW
HUM GENE THER. 2007; 18(10): 1016-1016.
Abstracts (Zeitschrift)

2006

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Spliceosome mediated RNA trans-splicing (SMaRT) is a novel method to treat autosomal dominant diseases
Wally, V; Klausegger, A; Koller, U; Lochmuller, H; Krause, S; Wiche, G; Mitchell, LG; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2006; 126: 32-32.
Abstracts (Zeitschrift)